• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2005-2017 年美国丙型肝炎病毒死亡率的县际差异及趋势

County-Level Variation in Hepatitis C Virus Mortality and Trends in the United States, 2005-2017.

机构信息

Department of EpidemiologyRollins School of Public HealthEmory UniversityAtlantaGA.

Immunization Services DivisionCenters for Disease Control and PreventionAtlantaGA.

出版信息

Hepatology. 2021 Aug;74(2):582-590. doi: 10.1002/hep.31756. Epub 2021 Jul 20.

DOI:10.1002/hep.31756
PMID:33609308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8456961/
Abstract

BACKGROUND AND AIMS

Since 2013, the national hepatitis C virus (HCV) death rate has steadily declined, but this decline has not been quantified or described on a local level.

APPROACH AND RESULTS

We estimated county-level HCV death rates and assessed trends in HCV mortality from 2005 to 2013 and from 2013 to 2017. We used mortality data from the National Vital Statistics System and used a Bayesian multivariate space-time conditional autoregressive model to estimate age-standardized HCV death rates from 2005 through 2017 for 3,115 U.S. counties. Additionally, we estimated county-level, age-standardized rates for persons <40 and 40+ years of age. We used log-linear regression models to estimate the average annual percent change in HCV mortality during periods of interest and compared county-level trends with national trends. Nationally, the age-adjusted HCV death rate peaked in 2013 at 5.20 HCV deaths per 100,000 persons (95% credible interval [CI], 5.12, 5.26) before decreasing to 4.34 per 100,000 persons (95% CI, 4.28, 4.41) in 2017 (average annual percent change = -4.69; 95% CI, -5.01, -4.33). County-level rates revealed heterogeneity in HCV mortality (2017 median rate = 3.6; interdecile range, 2.19, 6.77), with the highest rates being concentrated in the West, Southwest, Appalachia, and northern Florida. Between 2013 and 2017, HCV mortality decreased in 80.0% (n = 2,274) of all U.S. counties with a reliable trend estimate, with 25.8% (n = 803) of all counties experiencing a decrease larger than the national decline.

CONCLUSIONS

Although many counties have experienced a shift in HCV mortality trends since 2013, the magnitude and composition of that shift have varied by place. These data provide a better understanding of geographic differences in HCV mortality and can be used by local jurisdictions to evaluate HCV mortality in their areas relative to surrounding areas and the nation.

摘要

背景和目的

自 2013 年以来,全国丙型肝炎病毒(HCV)死亡率稳步下降,但这一下降在地方层面尚未量化或描述。

方法和结果

我们估计了县级 HCV 死亡率,并评估了 2005 年至 2013 年和 2013 年至 2017 年 HCV 死亡率的趋势。我们使用国家生命统计系统的死亡率数据,并使用贝叶斯多变量时空条件自回归模型,估计了 2005 年至 2017 年 3115 个美国县的年龄标准化 HCV 死亡率。此外,我们还估计了<40 岁和 40 岁以上人群的县级年龄标准化率。我们使用对数线性回归模型来估计感兴趣期间 HCV 死亡率的平均年变化百分比,并比较了县级趋势与全国趋势。在全国范围内,调整年龄后的 HCV 死亡率在 2013 年达到 5.20 HCV 死亡/每 10 万人(95%可信区间[CI],5.12,5.26)的峰值,然后在 2017 年下降至 4.34 HCV 死亡/每 10 万人(95% CI,4.28,4.41)(平均年变化百分比=-4.69;95% CI,-5.01,-4.33)。县级死亡率显示 HCV 死亡率存在异质性(2017 年中位数率=3.6;四分位间距,2.19,6.77),最高死亡率集中在西部、西南部、阿巴拉契亚和佛罗里达北部。在 2013 年至 2017 年期间,在有可靠趋势估计的所有美国县中,80.0%(n=2274)的 HCV 死亡率下降,其中 25.8%(n=803)的所有县的下降幅度大于全国下降幅度。

结论

尽管自 2013 年以来,许多县的 HCV 死亡率趋势发生了变化,但变化的幅度和构成因地点而异。这些数据提供了对 HCV 死亡率地理差异的更好理解,并可由地方当局用于评估其地区相对于周围地区和全国的 HCV 死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f8/8456961/22833cab0b1b/HEP-74-582-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f8/8456961/47f92811f4df/HEP-74-582-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f8/8456961/24fa0675392a/HEP-74-582-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f8/8456961/4547797e8680/HEP-74-582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f8/8456961/926ffda1a58f/HEP-74-582-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f8/8456961/22833cab0b1b/HEP-74-582-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f8/8456961/47f92811f4df/HEP-74-582-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f8/8456961/24fa0675392a/HEP-74-582-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f8/8456961/4547797e8680/HEP-74-582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f8/8456961/926ffda1a58f/HEP-74-582-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f8/8456961/22833cab0b1b/HEP-74-582-g004.jpg

相似文献

1
County-Level Variation in Hepatitis C Virus Mortality and Trends in the United States, 2005-2017.2005-2017 年美国丙型肝炎病毒死亡率的县际差异及趋势
Hepatology. 2021 Aug;74(2):582-590. doi: 10.1002/hep.31756. Epub 2021 Jul 20.
2
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.美国疾病控制与预防中心国家健康报告:2005 - 2013年美国发病和死亡的主要原因以及相关行为风险和保护因素
MMWR Suppl. 2014 Oct 31;63(4):3-27.
3
Stagnating National Declines in Stroke Mortality Mask Widespread County-Level Increases, 2010-2016.2010-2016 年,国家脑卒中死亡率下降趋于停滞,掩盖了广泛的县级上升趋势。
Stroke. 2019 Dec;50(12):3355-3359. doi: 10.1161/STROKEAHA.119.026695. Epub 2019 Nov 7.
4
Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.2006-2012 年美国非城市地区年轻静脉注射吸毒者中丙型肝炎病毒感染的新出现流行。
Clin Infect Dis. 2014 Nov 15;59(10):1411-9. doi: 10.1093/cid/ciu643. Epub 2014 Aug 11.
5
The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States.命运的逆转:美国各县死亡率趋势及县际死亡率差异
PLoS Med. 2008 Apr 22;5(4):e66. doi: 10.1371/journal.pmed.0050066.
6
Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014.1980 - 2014年美国各县心血管疾病死亡率的地理差异趋势与模式
JAMA. 2017 May 16;317(19):1976-1992. doi: 10.1001/jama.2017.4150.
7
Trends in Mortality From Drug Poisonings, Suicide, and Alcohol-Induced Deaths in the United States From 2000 to 2017.2000 年至 2017 年美国药物中毒、自杀和酒精相关死亡的死亡率趋势。
JAMA Netw Open. 2020 Sep 1;3(9):e2016217. doi: 10.1001/jamanetworkopen.2020.16217.
8
Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States.2004 - 2013年美国非都市和都市县的侵袭性癌症发病率以及2006 - 2015年的死亡情况
MMWR Surveill Summ. 2017 Jul 7;66(14):1-13. doi: 10.15585/mmwr.ss6614a1.
9
Historic and recent trends in county-level coronary heart disease death rates by race, gender, and age group, United States, 1979-2017.1979-2017 年美国按种族、性别和年龄组划分的县级冠心病死亡率的历史和近期趋势。
PLoS One. 2020 Jul 7;15(7):e0235839. doi: 10.1371/journal.pone.0235839. eCollection 2020.
10
Changing Spatiotemporal Trends in County-Level Heart Failure Death Rates in the United States, 1999 to 2018.美国 1999 年至 2018 年县级心力衰竭死亡率的时空变化趋势。
J Am Heart Assoc. 2021 Feb 16;10(4):e018125. doi: 10.1161/JAHA.120.018125. Epub 2021 Feb 4.

引用本文的文献

1
Hepatitis C Surveillance in the United States: Past, Present, and Future.美国丙型肝炎监测:过去、现在与未来
Public Health Rep. 2025 Aug 28:333549251351880. doi: 10.1177/00333549251351880.
2
Trends in Hepatitis C and Hepatitis B Deaths Identify Successes and Disparities, Alameda County, CA, 2005 - 2022.加利福尼亚州阿拉米达县2005 - 2022年丙型肝炎和乙型肝炎死亡趋势:揭示成功与差异
Gastroenterology Res. 2025 Jun 16;18(4):182-191. doi: 10.14740/gr2042. eCollection 2025 Aug.
3
Hepatitis C-Everything a Primary Care Physician Needs to Know About Diagnosis, Management, and Follow-Up.

本文引用的文献

1
Hexamaps for Age-Period-Cohort Data Visualization and Implementation in R.用于年龄-时期-队列数据可视化及在R语言中实现的六边形地图
Epidemiology. 2020 Nov 1;31(6):e47-e49. doi: 10.1097/EDE.0000000000001236.
2
Historic and recent trends in county-level coronary heart disease death rates by race, gender, and age group, United States, 1979-2017.1979-2017 年美国按种族、性别和年龄组划分的县级冠心病死亡率的历史和近期趋势。
PLoS One. 2020 Jul 7;15(7):e0235839. doi: 10.1371/journal.pone.0235839. eCollection 2020.
3
Vital Signs: Newly Reported Acute and Chronic Hepatitis C Cases - United States, 2009-2018.
丙型肝炎——基层医疗医生需要了解的关于诊断、管理及随访的一切。
J Clin Med. 2025 Jul 7;14(13):4801. doi: 10.3390/jcm14134801.
4
Chronic hepatitis C in hemodialysis patients: Prevalence and liver fibrosis impact in the National Center for Renal Health in Peru.秘鲁国家肾脏健康中心血液透析患者的慢性丙型肝炎:患病率及肝纤维化影响
ILIVER. 2022 Aug 24;1(3):141-144. doi: 10.1016/j.iliver.2022.08.001. eCollection 2022 Sep.
5
Trends in Mortality Caused by Hepatitis C Virus in the United States Population: A Retrospective Cross-Sectional Study Using the CDC WONDER Database.美国人群中丙型肝炎病毒所致死亡率的趋势:一项使用疾病控制与预防中心(CDC)WONDER数据库的回顾性横断面研究
Dig Dis Sci. 2025 Jun 18. doi: 10.1007/s10620-025-09161-1.
6
Insights into the spatial epidemiology of hepatitis C infection: systematic synthesis of area-level determinants and spatiotemporal analyses.丙型肝炎感染的空间流行病学洞察:区域层面决定因素的系统综合与时空分析
BMC Public Health. 2025 Feb 19;25(1):687. doi: 10.1186/s12889-025-21668-w.
7
Human Riboviruses: A Comprehensive Study.人类核糖病毒:一项全面研究。
J Mol Evol. 2025 Feb;93(1):11-37. doi: 10.1007/s00239-024-10221-9. Epub 2024 Dec 31.
8
Disparities in hepatitis C among people aged 12-59 with no history of injection drug use, United States, January 2013-March 2020.2013 年 1 月至 2020 年 3 月期间,美国无注射吸毒史的 12-59 岁人群中的丙型肝炎差异。
Liver Int. 2024 Dec;44(12):3250-3259. doi: 10.1111/liv.16108. Epub 2024 Sep 26.
9
Subspecialty physicians' perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study.亚专科医生对丙型肝炎治疗障碍和促进因素的看法:一项定性研究。
Harm Reduct J. 2024 Jul 25;21(1):140. doi: 10.1186/s12954-024-01057-z.
10
Estimated Number of Injection-Involved Overdose Deaths in US States From 2000 to 2020: Secondary Analysis of Surveillance Data.2000 年至 2020 年美国各州注射用药过量死亡人数估计:监测数据的二次分析。
JMIR Public Health Surveill. 2024 Apr 5;10:e49527. doi: 10.2196/49527.
生命体征:2009-2018 年美国新报告的急性和慢性丙型肝炎病例。
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):399-404. doi: 10.15585/mmwr.mm6914a2.
4
CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020.美国疾病预防控制中心关于 2020 年成年人丙型肝炎筛查的建议。
MMWR Recomm Rep. 2020 Apr 10;69(2):1-17. doi: 10.15585/mmwr.rr6902a1.
5
Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013-2016.2013 - 2016年美国50个州及华盛顿特区按性别、出生队列和种族划分的丙型肝炎病毒流行情况
Hepatol Commun. 2020 Jan 14;4(3):355-370. doi: 10.1002/hep4.1457. eCollection 2020 Mar.
6
Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysis.直接作用抗病毒联合治疗时代丙型肝炎的治疗优化:一项系统评价和荟萃分析
Wellcome Open Res. 2019 Sep 6;4:132. doi: 10.12688/wellcomeopenres.15411.1. eCollection 2019.
7
Stagnating National Declines in Stroke Mortality Mask Widespread County-Level Increases, 2010-2016.2010-2016 年,国家脑卒中死亡率下降趋于停滞,掩盖了广泛的县级上升趋势。
Stroke. 2019 Dec;50(12):3355-3359. doi: 10.1161/STROKEAHA.119.026695. Epub 2019 Nov 7.
8
Deaths Associated With Hepatitis C Virus Infection Among Residents in 50 States and the District of Columbia, 2016-2017.2016-2017 年美国 50 个州和哥伦比亚特区居民丙型肝炎病毒感染相关死亡人数。
Clin Infect Dis. 2020 Aug 22;71(5):1149-1160. doi: 10.1093/cid/ciz976.
9
Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.在美国扩大 HCV 预防和治疗规模以预防和治疗注射毒品人群的成本效益。
Addiction. 2019 Dec;114(12):2267-2278. doi: 10.1111/add.14731. Epub 2019 Aug 2.
10
Comprehensive nationwide chronic hepatitis C surveillance is necessary for accurate state-level prevalence estimates.全面的全国性丙型肝炎慢性监测对于准确估计各州患病率是必要的。
J Viral Hepat. 2019 Sep;26(9):1124-1126. doi: 10.1111/jvh.13124. Epub 2019 Jun 5.